Matthew Baker
About Matthew Baker
Matthew Baker is the Executive Director of US Oncology Marketing at Bristol Myers Squibb in Princeton, NJ, specializing in innovative strategies for cancer treatments.
Company
Matthew Baker is currently employed at Bristol Myers Squibb, a globally recognized biopharmaceutical company. Based in Princeton, NJ, Bristol Myers Squibb focuses on discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Matthew Baker contributes significantly to the company's mission, leveraging his expertise in oncology marketing.
Title
Matthew Baker serves as the Executive Director of US Oncology, Marketing at Bristol Myers Squibb. In this senior role, he leads the development and execution of marketing strategies aimed at promoting the company's oncology treatments. His work focuses on driving innovative approaches in the marketing of cancer therapies.
Education and Expertise
Matthew Baker holds a Bachelor of Science degree in Psychology, Marketing from the University of Melbourne, where he studied from 2001 to 2004. His academic background in psychology and marketing has provided him with deep insights into consumer behavior and strategic marketing approaches. He also attended St Bernards College prior to his university education.
Professional Background
Matthew Baker has been with Bristol Myers Squibb for over 17 years, beginning his tenure in January 2006. Over the years, he has played a crucial role in various capacities, ultimately rising to his current position as Executive Director of US Oncology, Marketing. His long-term affiliation with the company underscores his commitment and significant contribution to the field.
Specialization in Oncology Marketing
Specializing in oncology marketing, Matthew Baker focuses on innovative strategies to promote cancer treatments. His work involves understanding the competitive landscape, identifying market needs, and developing targeted marketing campaigns. His expertise helps Bristol Myers Squibb to effectively communicate the benefits of their oncology products to healthcare providers and patients.